Tags

Type your tag names separated by a space and hit enter

Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
S Afr Med J. 1989 Nov 18; 76(10):546-7.SA

Abstract

Patients with Plasmodium falciparum infections in northern KwaZulu adjacent to the Mozambique border were treated with chloroquine 25 mg/kg. Persistent parasitaemias increased from nil in 1983 to 21.2% and 16.1% for hospital and field treatments respectively in 1987. After a change to sulfadoxine-pyrimethamine (Fansidar; Roche) treatment (adults 1,500 mg and 75 mg respectively) these rates fell in March 1988 to 6.9% and 0.4%.

Authors+Show Affiliations

Department of National Health and Population Development, Tzaneen, Tvl.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

2686047

Citation

Hansford, C F.. "Chloroquine Resistance in Plasmodium Falciparum in KwaZulu, 1983-1988." South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde, vol. 76, no. 10, 1989, pp. 546-7.
Hansford CF. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988. S Afr Med J. 1989;76(10):546-7.
Hansford, C. F. (1989). Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde, 76(10), 546-7.
Hansford CF. Chloroquine Resistance in Plasmodium Falciparum in KwaZulu, 1983-1988. S Afr Med J. 1989 Nov 18;76(10):546-7. PubMed PMID: 2686047.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988. A1 - Hansford,C F, PY - 1989/11/18/pubmed PY - 1989/11/18/medline PY - 1989/11/18/entrez SP - 546 EP - 7 JF - South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde JO - S Afr Med J VL - 76 IS - 10 N2 - Patients with Plasmodium falciparum infections in northern KwaZulu adjacent to the Mozambique border were treated with chloroquine 25 mg/kg. Persistent parasitaemias increased from nil in 1983 to 21.2% and 16.1% for hospital and field treatments respectively in 1987. After a change to sulfadoxine-pyrimethamine (Fansidar; Roche) treatment (adults 1,500 mg and 75 mg respectively) these rates fell in March 1988 to 6.9% and 0.4%. SN - 0256-9574 UR - https://www.unboundmedicine.com/medline/citation/2686047/Chloroquine_resistance_in_Plasmodium_falciparum_in_KwaZulu_1983_1988_ L2 - https://medlineplus.gov/malaria.html DB - PRIME DP - Unbound Medicine ER -